Experience with paroxetine in the treatment of depressions. Results of a post-marketing surveillance study in 1242 patients;Praktische erfahrungen mit paroxetin in der depressionsbehandlung. Ergebnisse einer anwendungsbeobachtung an 1242 patienten

Neuropsychiatrie

Volumn 12, Issue 2, 1998, Pages 110-115

  Simhandl, C ^a,c   Leitner, B ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medizinische Abteilung   (Austria)

^c NONE   (Austria)

Author keywords

Depression; Efficacy; Paroxetine; Post marketing surveillance; Safety

Indexed keywords

PAROXETINE;

ADULT; AGED; ARTICLE; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; TREATMENT OUTCOME;

EID: 0031901887     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. American Psychiatrie Association: Diagnostische Kriterien und Differentialdiagnosen des Diagnostischen und Statistischen Manuals Psychischer Störungen DSM-III-R. Beltz, Weinheim 1989.
2. Bochnik H.J., H. Koch: Praxen, Kompetenzen, Patienten. Dt. Ärzteverlag, Köln 1990.
3. Duboff E.A.: Long-term treatment of major depressive disorder with paroxetine. J. Clin. Psychopharmacol. 13 (Suppl.2), S28-S33 (1993).
4. Dunner D.L., G. C. Dunbar: Optimal dose regimen for paroxetine. J. Clin. Psychiatry 53 (Suppl.), 21-26 (1992).
5. Gunasekara N.S. et al.: Paroxetine - An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs 55, 85-120 (1998).
6. Hamilton M.: Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol 6, 278-296 (1967).
7. Lecrubier Y. et al.: Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatr. Scand 95, 153-160 (1997).
8. Lépine J.P. et al.: Depression in the community: the first pan-European study DEPRES (Depression Research in European Societey). Int. Clin. Psychopharmacol. 12, 19-29 (1997).
9. Ontiveros A.: A double-blind, comparative study of paroxetine and fluoxetine in out-patients with depression. Br. J. Clin. Res. 8, 23-32 (1997).
10. Rocca P. et al.: Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr. Scand. 95, 444-450 (1997).
11. Tignol J.: Treatment of severe depression with paroxetine. Eur. Psychiatry 8, 21-23 (1993).
12. Weltgesundheitsorganisation, Dilling H. et al. (Hrsg.): Internationale Klassifikation psychischer Störungen - ICD-10. H. Huber, Lübeck 1992.
13. Wolfersdorf M.: Depressionsbehandlung mit Paroxetin - Ergebnisse einer Anwendungsbeobachtung in der allgemeinärztlichen Praxis. Therapiewoche 33, 1811-1815 (1996).
14. Wolfersdorf M. et al: Paroxetine in the treatment of inpatients with non-delusional endogenous or neurotic depression. Schweiz Arch. Neurol. Psychiatr. 145, 15-18 (1994).
15. Zaninelli R., W. Meister: The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring. Pharmacopsychiat. 30 (Suppl.), 9-20 (1997).
16. Zohar J. et al.: Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br. J. Psychiatry 169, 468-474 (1996).